Otc - Active Ingredient
MEDICAGO SATIVA WHOLE
CHICORY ROOT
GLUCOSAMINE HYDROCHLORIDE
BUCKWHEAT
TEA LEAF
MORUS ALBA LEAF
LICORICE
FU LING
COIX LACRYMA-JOBI SEED
ANSERINE
Gout Relief 3310a Plus Tablet
FDA Label NDC 85631-009
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Bispit Canada Ltd. for the product Gout Relief 3310a Plus (NDC 85631-009). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, warnings, otc - keep out of reach of children, otc - purpose, dosage & administration, indications & usage, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
CALCIUM CARBONATE
SODIUM CHLORIDE
Warnings
Ulsing three bottles is generally effective fordissolving crystals (as crystal dissoiution takestime);
You should experience noticeable effects afterat least 21 days of conbnlous use,It is noral to experence increose in uric acidlevels or gout recurrencelchanges imn affectedareas during the early days of use;Refrain from olcohol consumption, or limit itsionificantly, for at least 15 days before takingthis product;
lt has an auxiliary effect on improving libidoand supporting prostate health,
Do not use if you have a seafood allergy.
Store properly and out of reach of children.
Otc - Keep Out Of Reach Of Children
Store properly and out of reach of children.
Otc - Purpose
This product is a pure plant extract; it canreduce the frequency of goutattacks; dissolve the crystals in thejoints; promote the excretion of blood uricacids,andimprove the purine metabolismand excretory system.
Dosage & Administration
2 tablets in the momingand 2 toblets in the evening.
Indications & Usage
Applicable Population:patient with gout,high uric acid, depositionof urate crystal, kidney stone and bladder
stone.
Package Label.Principal Display Panel
Labeling (85631 009 01 0906)
* Please review the disclaimer below.
